RERFX
Price
$56.88
Change
-$0.02 (-0.04%)
Updated
Feb 26, 6:59 PM EST
RIVLX
Price
$16.81
Change
-$0.00 (-0.00%)
Updated
Feb 26, 6:59 PM EST
Ad is loading...

Compare predictions RERFX vs RIVLX

Header iconRERFX vs RIVLX Comparison
Open Charts RERFX vs RIVLXBanner chart's image
American Funds Europacific Growth R5
Price$56.88
Change-$0.02 (-0.04%)
VolumeN/A
CapitalizationN/A
American Funds International Vntg R-5
Price$16.81
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
RERFX vs RIVLX Comparison Chart

Loading...

VS
RERFX vs. RIVLX commentary
Feb 27, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RERFX is a Hold and RIVLX is a Hold.

FUNDAMENTALS
Fundamentals
RERFX has more cash in the bank: 138B vs. RIVLX (1.96B). RERFX pays higher dividends than RIVLX: RERFX (1.92) vs RIVLX (1.53). RERFX was incepted earlier than RIVLX: RERFX (22 years) vs RIVLX (4 years). RIVLX (0.61) is less costly to investors than RERFX (0.52). RERFX is a more actively managed with annual turnover of: 34.00 vs. RIVLX (15.00). RERFX (250) and RIVLX (250) have matching initial minimum investment requirements. RIVLX annual gain was more profitable for investors over the last year : 14.45 vs. RERFX (13.46).
RERFXRIVLXRERFX / RIVLX
Total Expense Ratio0.520.5988%
Annual Report Gross Expense Ratio0.520.6185%
Fund Existence22 years4 years-
Gain YTD4.1193.066134%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRA0N/A-
Net Assets138B1.96B7,052%
Annual Yield % from dividends1.921.53126%
Returns for 1 year13.4614.4593%
Returns for 3 years-14.127.41-191%
Returns for 5 years19.53N/A-
Returns for 10 years23.20N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NVCT9.271.75
+23.27%
Nuvectis Pharma
YELP36.680.72
+2.00%
YELP
GNPX4.410.05
+1.15%
Genprex
AGR30.93-1.15
-3.58%
Avangrid
PHAT9.91-0.69
-6.51%
Phathom Pharmaceuticals